基于CT的身体成分评估与上皮性卵巢癌新辅助化疗期间患者结局的关联
该研究纳入2008至2020年间接受新辅助化疗的上皮性卵巢癌患者174例,通过治疗前后增强CT测量第四腰椎中段骨骼肌指数(SMI)和内脏脂肪组织(VAT)面积,分析其与临床变量及结局的关联。结果发现较低的预处理SMI与较低的手术复杂性评分及估计失血量相关,SMI下降与ICU入住率和住院时间增加相关,而VAT每100天下降超过2%与更差的总生存期显著相关。
要点
- 基线SMI较低的患者接受的手术复杂性评分更低(p<0.001),估计失血量更少(p=0.029)。
- 新辅助化疗后SMI下降与ICU入住率及住院时间增加相关。
- VAT每100天下降超过2%与更差的总生存期显著相关。
核心结论
- 预处理SMI较低的患者尽管接受新辅助化疗,仍倾向于接受较不复杂的手术。
- VAT下降可能是总生存期较差的潜在指标。
- 身体成分信息可辅助上皮性卵巢癌患者的临床决策。
研究设计与样本
- 研究纳入2008年至2020年间接受新辅助化疗的上皮性卵巢癌患者174例。
- 回顾治疗前和治疗后增强CT,测量第四腰椎中段骨骼肌指数(SMI)和内脏脂肪组织(VAT)面积。
- 分析SMI和VAT与临床及治疗变量的关联。
主要发现
- 预处理平均SMI为38.3 cm2/m2 ± 7.9,平均VAT为51.2 cm2/m2 ± 34.3。
- 治疗后平均SMI为37.8 cm2/m2 ± 7.9,平均VAT为43.7 cm2/m2 ± 29.7。
- 大多数患者从预处理到治疗后扫描SMI总体下降。
- 诊断时白人种族、较大年龄和较低体重指数与较低的预处理SMI相关。
- 较低的预处理SMI与较低的手术复杂性评分(p < 0.001)和估计失血量(p = 0.029)相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to characterize the body composition of patients undergoing neoadjuvant chemotherapy (NACT) for epithelial ovarian cancer (EOC), identify factors associated with sarcopenia at diagnosis, and evaluate the impact of pretreatment sarcopenia and changes in body composition parameters during therapy on perioperative and disease-related outcomes. METHODS: Patients undergoing NACT for EOC between 2008 and 2020 were identified. Pre-treatment and post-treatment contrast-enhanced CT scans were reviewed to determine skeletal muscle index (SMI) and visceral adipose tissue (VAT) area at the mid-fourth lumbar vertebral level. SMI and VAT were analyzed for association with clinical and treatment variables. RESULTS: 174 patients were identified. Mean pretreatment SMI and VAT were 38.3 cm2/m2 ± 7.9 and 51.2 cm2/m2 ± 34.3, respectively. Comparatively, mean post-treatment SMI and VAT were 37.8 cm2/m2 ± 7.9 and 43.7 cm2/m2 ± 29.7, respectively. Most patients exhibited an overall decrease in SMI from pretreatment to posttreatment scans. Caucasian race, older age, and lower body mass index at diagnosis were associated with lower pretreatment SMI. Lower pre-treatment SMI was associated with lower surgical complexity scores (p < 0.001) and estimated blood loss (p = 0.029). Decrease in SMI after NACT was associated with increased rates of ICU admissions and length of stay. While there was no association between SMI and overall survival (OS) or progression-free survival (PFS), >2% decrease per 100 days in VAT was significantly associated with worse OS. CONCLUSIONS: Patients with lower pretreatment SMI tend to undergo less complex surgery than those with higher SMI despite NACT. Decrease in VAT may be a potential indicator of worse OS. Information on body composition can aid in clinical decision making in patients with EOC.
引用
- Wood N, Morton M, Shah SN, et al. Association between CT-based body composition assessment and patient outcomes during neoadjuvant chemotherapy for epithelial ovarian cancer. Gynecol Oncol. 2022. PMID: 36508759. doi:10.1016/j.ygyno.2022.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。